CD147 and AGR2 expression promote cellular proliferation and metastasis of head and neck squamous cell carcinoma

Experimental Cell Research

Volumn 318, Issue 14, 2012, Pages 1788-1798

  Sweeny, Larissa ^a   Liu, Zhiyong ^a   Bush, Benjamin D ^a   Hartman, Yolanda ^a   Zhou, Tong ^b   Rosenthal, Eben L ^a  

^a Kentucky   (United States)

^b Shelby Biomedical Research Building 302   (United States)

Author keywords

Aerodigestive squamous cell carcinoma; CD147; Head and neck; HNSCC; Metastasis

Indexed keywords

CD147 ANTIGEN; PROTEIN; PROTEIN AGR2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; CERVICAL LYMPH NODE; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; GENE SILENCING; HEAD AND NECK SQUAMOUS CELL CARCINOMA; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; LYMPH NODE METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR GROWTH;

EID: 84862839301     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2012.04.022     Document Type: Article

References (45)

1. Anderson A.R. A hybrid mathematical model of solid tumour invasion: the importance of cell adhesion. Math. Med. Biol.: J. IMA 2005, 22:163-186.
2. Maekawa K., Sato H., Furukawa M., Yoshizaki T. Inhibition of cervical lymph node metastasis by marimastat (BB-2516) in an orthotopic oral squamous cell carcinoma implantation model. Clin. Exp. Metastasis 2002, 19:513-518.
3. Yu T., Wu Y., Helman J.I., Wen Y., Wang C., Li L. CXCR4 promotes oral squamous cell carcinoma migration and invasion through inducing expression of MMP-9 and MMP-13 via the ERK signaling pathway. Mol. Cancer Res. 2011, 9:161-172.
4. Y. Liu, C. Yu, Y. Qiu, D. Huang, X. Zhou, X. Zhang, Y. Tian, Downregulation of EphA2 expression suppresses the growth and metastasis in squamous-cell carcinoma of the head and neck in vitro and in vivo, J. Cancer Res. Clin. Oncol. (2011).
5. Biswas C., Zhang Y., DeCastro R., Guo H., Nakamura T., Kataoka H., Nabeshima K. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res. 1995, 55:434-439.
6. Rosenthal E.L., Shreenivas S., Peters G.E., Grizzle W.E., Desmond R., Gladson C.L. Expression of extracellular matrix metalloprotease inducer in laryngeal squamous cell carcinoma. Laryngoscope 2003, 113:1406-1410.
7. Riethdorf S., Reimers N., Assmann V., Kornfeld J.W., Terracciano L., Sauter G., Pantel K. High incidence of EMMPRIN expression in human tumors. Int. J. Cancer 2006, 119:1800-1810.
8. Rosenthal E.L., Zhang W., Talbert M., Raisch K.P., Peters G.E. Extracellular matrix metalloprotease inducer-expressing head and neck squamous cell carcinoma cells promote fibroblast-mediated type I collagen degradation in vitro. Mol. Cancer Res. 2005, 3:195-202.
9. Tang Y., Nakada M.T., Kesavan P., McCabe F., Millar H., Rafferty P., Bugelski P., Yan L. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases. Cancer Res. 2005, 65:3193-3199.
10. Vigneswaran N., Beckers S., Waigel S., Mensah J., Wu J., Mo J., Fleisher K.E., Bouquot J., Sacks P.G., Zacharias W. Increased EMMPRIN (CD 147) expression during oral carcinogenesis. Exp. Mol. Pathol. 2006, 80:147-159.
11. Maatta M., Tervahartiala T., Kaarniranta K., Tang Y., Yan L., Tuukkanen J., Sorsa T. Immunolocalization of EMMPRIN (CD147) in the human eye and detection of soluble form of EMMPRIN in ocular fluids. Curr. Eye Res. 2006, 31:917-924.
12. Bordador L.C., Li X., Toole B., Chen B., Regezi J., Zardi L., Hu Y., Ramos D.M. Expression of emmprin by oral squamous cell carcinoma, International journal of cancer. J. Int. du Cancer 2000, 85:347-352.
13. Chen Z., Mi L., Xu J., Yu J., Wang X., Jiang J., Xing J., Shang P., Qian A., Li Y., Shaw P.X., Wang J., Duan S., Ding J., Fan C., Zhang Y., Yang Y., Yu X., Feng Q., Li B., Yao X., Zhang Z., Li L., Xue X., Zhu P. Function of HAb18G/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus. J. Infect. Dis. 2005, 191:755-760.
14. Yang J.M., Xu Z., Wu H., Zhu H., Wu X., Hait W.N. Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells. Mol. Cancer Res.: MCR 2003, 1:420-427.
15. Kuang Y.H., Chen X., Su J., Wu L.S., Li J., Chang J., Qiu Y., Chen Z.S., Kanekura T. Proteome analysis of multidrug resistance of human oral squamous carcinoma cells using CD147 silencing. J. Proteome Res. 2008, 7:4784-4791.
16. Huang C., Sun Z., Sun Y., Chen X., Zhu X., Fan C., Liu B., Zhao Y., Zhang W. Association of increased ligand cyclophilin A and receptor CD147 with hypoxia, angiogenesis, metastasis and prognosis of tongue squamous cell carcinoma. Histopathol. 2012.
17. Huang Z., Huang H., Li H., Chen W., Pan C. EMMPRIN expression in tongue squamous cell carcinoma. J. Oral Pathol. Med. 2009, 38:518-523.
18. Cheng M.F., Tzao C., Tsai W.C., Lee W.H., Chen A., Chiang H., Sheu L.F., Jin J.S. Expression of EMMPRIN and matriptase in esophageal squamous cell carcinoma: correlation with clinicopathological parameters. Dis. Esophagus 2006, 19:482-486.
19. Zheng H.C., Takahashi H., Murai Y., Cui Z.G., Nomoto K., Miwa S., Tsuneyama K., Takano Y. Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis. Br. J. Cancer 2006, 95:1371-1378.
20. Zheng H.C., Wang W., Xu X.Y., Xia P., Yu M., Sugiyama T., Takano Y. Up-regulated EMMPRIN/CD147 protein expression might play a role in colorectal carcinogenesis and its subsequent progression without an alteration of its glycosylation and mRNA level. J. Cancer Res. Clin. Oncol. 2011, 137:585-596.
21. Wang Z., Hao Y., Lowe A.W. The adenocarcinoma-associated antigen, AGR2, promotes tumor growth, cell migration, and cellular transformation. Cancer Res. 2008, 68:492-497.
22. Maresh E.L., Mah V., Alavi M., Horvath S., Bagryanova L., Liebeskind E.S., Knutzen L.A., Zhou Y., Chia D., Liu A.Y., Goodglick L. Differential expression of anterior gradient gene AGR2 in prostate cancer. BMC Cancer 2010, 10:680.
23. Thompson D.A., Weigel R.J. hAG-2, the human homologue of the Xenopus laevis cement gland gene XAG-2, is coexpressed with estrogen receptor in breast cancer cell lines. Biochem. Biophys. Res. Commun. 1998, 251:111-116.
24. Fritzsche F.R., Dahl E., Pahl S., Burkhardt M., Luo J., Mayordomo E., Gansukh T., Dankof A., Knuechel R., Denkert C., Winzer K.J., Dietel M., Kristiansen G. Prognostic relevance of AGR2 expression in breast cancer. Clin. Cancer Res. 2006, 12:1728-1734.
25. Zhang J.S., Gong A., Cheville J.C., Smith D.I., Young C.Y. AGR2, an androgen-inducible secretory protein overexpressed in prostate cancer. Genes Chromosomes Cancer 2005, 43:249-259.
26. Zhang Y., Forootan S.S., Liu D., Barraclough R., Foster C.S., Rudland P.S., Ke Y. Increased expression of anterior gradient-2 is significantly associated with poor survival of prostate cancer patients. Prostate Cancer Prostatic Dis. 2007, 10:293-300.
27. Riener M.O., Pilarsky C., Gerhardt J., Grutzmann R., Fritzsche F.R., Bahra M., Weichert W., Kristiansen G. Prognostic significance of AGR2 in pancreatic ductal adenocarcinoma. Histol. Histopathol. 2009, 24:1121-1128.
28. Fritzsche F.R., Dahl E., Dankof A., Burkhardt M., Pahl S., Petersen I., Dietel M., Kristiansen G. Expression of AGR2 in non small cell lung cancer. Histol. Histopathol. 2007, 22:703-708.
29. Park K., Chung Y.J., So H., Kim K., Park J., Oh M., Jo M., Choi K., Lee E.J., Choi Y.L., Song S.Y., Bae D.S., Kim B.G., Lee J.H. AGR2, a mucinous ovarian cancer marker, promotes cell proliferation and migration. Exp. Mol. Med. 2011, 43:91-100.
30. Liu D., Rudland P.S., Sibson D.R., Platt-Higgins A., Barraclough R. Human homologue of cement gland protein, a novel metastasis inducer associated with breast carcinomas. Cancer Res. 2005, 65:3796-3805.
31. Zweitzig D.R., Smirnov D.A., Connelly M.C., Terstappen L.W., O'Hara S.M., Moran E. Physiological stress induces the metastasis marker AGR2 in breast cancer cells. Mol. Cellular Biochem. 2007, 306:255-260.
32. Park S.W., Zhen G., Verhaeghe C., Nakagami Y., Nguyenvu L.T., Barczak A.J., Killeen N., Erle D.J. The protein disulfide isomerase AGR2 is essential for production of intestinal mucus. Proc. Natl. Acad. Sci. USA 2009, 106:6950-6955.
33. Zhang Y., Ali T.Z., Zhou H., D'Souza D.R., Lu Y., Jaffe J., Liu Z., Passaniti A., Hamburger A.W. ErbB3 binding protein 1 represses metastasis-promoting gene anterior gradient protein 2 in prostate cancer. Cancer Res. 2010, 70:240-248.
34. Liu Z., Hartman Y.E., Warram J.M., Knowles J.A., Sweeny L., Zhou T., Rosenthal E.L. Fibroblast growth factor receptor mediates fibroblast-dependent growth in EMMPRIN-depleted head and neck cancer tumor cells. Mol. Cancer Res. 2011, 9:1008-1017.
35. Dean N.R., Newman J.R., Helman E.E., Zhang W., Safavy S., Weeks D.M., Cunningham M., Snyder L.A., Tang Y., Yan L., McNally L.R., Buchsbaum D.J., Rosenthal E.L. Anti-EMMPRIN monoclonal antibody as a novel agent for therapy of head and neck cancer. Clin. Cancer Res. 2009, 15:4058-4065.
36. Gleysteen J.P., Newman J.R., Chhieng D., Frost A., Zinn K.R., Rosenthal E.L. Fluorescent labeled anti-EGFR antibody for identification of regional and distant metastasis in a preclinical xenograft model. Head Neck 2008, 30:782-789.
37. Kulbersh B.D., Duncan R.D., Magnuson J.S., Skipper J.B., Zinn K., Rosenthal E.L. Sensitivity and specificity of fluorescent immunoguided neoplasm detection in head and neck cancer xenografts. Arch. Otolaryngol. Head Neck Surg. 2007, 133:511-515.
38. Rosenthal E.L., Kulbersh B.D., King T., Chaudhuri T.R., Zinn K.R. Use of fluorescent labeled anti-epidermal growth factor receptor antibody to image head and neck squamous cell carcinoma xenografts. Mol. Cancer Ther. 2007, 6:1230-1238.
39. Erdem N.F., Carlson E.R., Gerard D.A., Ichiki A.T. Characterization of 3 oral squamous cell carcinoma cell lines with different invasion and/or metastatic potentials. J. Oral Maxillofac. Surg. 2007, 65:1725-1733.
40. Marieb E.A., Zoltan-Jones A., Li R., Misra S., Ghatak S., Cao J., Zucker S., Toole B.P. Emmprin promotes anchorage-independent growth in human mammary carcinoma cells by stimulating hyaluronan production. Cancer Res. 2004, 64:1229-1232.
41. Quemener C., Gabison E.E., Naimi B., Lescaille G., Bougatef F., Podgorniak M.P., Labarchede G., Lebbe C., Calvo F., Menashi S., Mourah S. Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion. Cancer Res. 2007, 67:9-15.
42. Yan L., Zucker S., Toole B.P. Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression. Thromb. Haemost. 2005, 93:199-204.
43. Newman J.R., Bohannon I.A., Zhang W., Skipper J.B., Grizzle W.E., Rosenthal E.L. Modulation of tumor cell growth in vivo by extracellular matrix metalloprotease inducer. Arch. Otolaryngol. Head Neck Surg. 2008, 134:1218-1224.
44. Tsukifuji R., Tagawa K., Hatamochi A., Shinkai H. Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis. Br. J. Cancer 1999, 80:1087-1091.
45. Sutinen M., Kainulainen T., Hurskainen T., Vesterlund E., Alexander J.P., Overall C.M., Sorsa T., Salo T. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis. Br. J. Cancer 1998, 77:2239-2245.